Talk to the Institute
No verified portrait

Paresh Patel

Director, Exzeo Group, Inc.

Since Jan 1, 2020.

Record corroboratedProfile not claimedPeople are not rated
Follow recordSave PDF
Alpha ID
alpha:person:purav-patel
Record version
vpublic-0:d751713988987e9331980363e24189ce, published Sep 2, 2026
Newest evidence
Apr 29, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
Current role
DirectorSince Jan 1, 2020
Board seats
3Exzeo Group, Inc., REVIVA PHARMACEUTICALS HOLDINGS, INC.
Committee seats
0None published
Published claims
267 distinct sources
Evidence records
140 pinned
Source conflicts
0None open

Built from 7 distinct sources and 14 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public-role record. Alpha publishes facts about this person's role at an organization in the public Registry, drawn from regulatory filings and company statements, and nothing about private life. Any person or agent may read it. The subject can correct, dispute, or object. How this works

DIRECTOR APPOINTED

Paresh Patel seat on Exzeo Group, Inc., effective 2020-01-01.

EffectiveEffective Jan 1, 2020E2

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencecorroborated
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Board service

Evidence

Seats held as a director, as published in the cited sources.

Exzeo Group, Inc. CurrentDirector, 2020 to present. Chairman of the Board and Chief Executive Officer, Current · dates not publishedOpen recordREVIVA PHARMACEUTICALS HOLDINGS, INC. CurrentDirector, 2020 to presentRecord pendingHCI Group, Inc. CurrentDirector, 2007 to presentOpen record
Professional RoleDirector at Exzeo Group, Inc.
Source reportedE2
person:purav-patel:role:1
Professional RoleDirector at REVIVA PHARMACEUTICALS HOLDINGS, INC.
Source reportedE11
person:purav-patel:role:2
Professional RoleDirector at HCI Group, Inc.
Source reportedE3
person:purav-patel:role:3
Professional RoleChairman of the Board and Chief Executive Officer at Exzeo Group, Inc.
Source reportedE4
person:purav-patel:role:5
Board membershipServes on the board of Exzeo Group, Inc.
Source reportedE12
person:purav-patel:board_membership:2
Board membershipServes on the board of HCI Group, Inc.
Source reportedE14
person:purav-patel:board_membership:3
Board membershipServes on the board of REVIVA PHARMACEUTICALS HOLDINGS, INC.
Source reportedE13
person:purav-patel:board_membership:4
Board roleBoard role: Director
Source reportedE10
person:purav-patel:board_role:5
Committee assignmentsCommittee assignments: Audit, Compensation, Nominating/Governance
Source reportedE10
person:purav-patel:committee_assignments:6

Committee experience

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Work experience

Evidence
  1. Current · dates not published
    Chairman and Chief Executive OfficerExzeo Group, Inc.
    E4
  2. 2026 to end not published
    Executive title: DirectorOrganization not published
    E5
  3. 2026 to end not published
    Executive title: Chairman and Chief Executive OfficerOrganization not published
    E1E6
  4. 2026 to end not published
    Executive title: PresidentOrganization not published
    E7
  5. 2026 to end not published
    Executive title: Chief Executive OfficerOrganization not published
    E8E9
  6. Dates not published
    Executive title: Founder and Managing PartnerOrganization not published
    E10

Education, credentials, and certifications

Evidence

No education, credentials, or certifications are published in this record.

No published claims

No education, credentials, or certifications are published in this record.

AI, cyber, and technology accountability

Evidence
AI and ML experienceAI and ML experience: not identified in the cited filing
CorroboratedE10E1
person:purav-patel:ai_ml_experience:1
Technology backgroundTechnology background: not identified in the cited filing
Source reportedE10
person:purav-patel:technology_background:20
Technology backgroundTechnology background reported in filings
Source reportedE1
person:purav-patel:technology_background:21

Authority to act

Evidence and agent registry

Who may act on this authority. An agent about to transact, or one presenting itself as acting under this authority, checks these Claims first.

Officer of recordDirector, Exzeo Group, Inc., from Jan 1, 2020
Source reportedE2
person:purav-patel:role:1
Officer of recordDirector, REVIVA PHARMACEUTICALS HOLDINGS, INC., from Jan 1, 2020
Source reportedE11
person:purav-patel:role:2
Officer of recordDirector, HCI Group, Inc., from Jan 1, 2007
Source reportedE3
person:purav-patel:role:3
Officer of recordChairman and Chief Executive Officer, Exzeo Group, Inc.
Source reportedE4
person:purav-patel:role:4
Officer of recordChairman of the Board and Chief Executive Officer, Exzeo Group, Inc.
Source reportedE4
person:purav-patel:role:5
Authority to bind the companyNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents acting on this authorityNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations grantedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Compensation and holdings

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Conflicts and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Cybersecurity experienceCybersecurity experience: not identified in the cited filing
CorroboratedE10E1
person:purav-patel:cybersecurity_experience:7
Executive companyExecutive at Buena Vista Fund I
Source reportedE10
person:purav-patel:executive_company:8
Executive companyExecutive at Crown Reserve Acquisition Corp. I
Source reportedE6
person:purav-patel:executive_company:9
Executive companyExecutive at Exzeo Group, Inc.
Source reportedE1
person:purav-patel:executive_company:10
Executive companyExecutive at HCI Group, Inc.
CorroboratedE8E9
person:purav-patel:executive_company:11
Executive companyExecutive at REVIVA PHARMACEUTICALS HOLDINGS, INC.
Source reportedE5
person:purav-patel:executive_company:12
Executive companyExecutive at Wellgistics Health, Inc.
Source reportedE7
person:purav-patel:executive_company:13
Other Company RoleParesh Patel is also linked to HCI as Chairman and Chief Executive Officer.
Source reportedE1
person:purav-patel:other_company_role:19

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Only permissioned public claims and evidence are included.Only permissioned public claims and evidence are included.
  • Absence of a claim is not evidence that the underlying fact is false.Absence of a claim is not evidence that the underlying fact is false.
  • Public retrieval does not grant model-training or redistribution rights.Public retrieval does not grant model-training or redistribution rights.
  • Private relationships and Council activity are excluded.Private relationships and Council activity are excluded.

Subject and corrections

Public-role doctrine

This record exists because the subject holds a public role. The subject can claim the profile, correct, dispute, or object. Subject statements appear as their own assertion state and never overwrite the evidence.

Basis
Public role at an organization in the published Registry
Sources
14 evidence records cited. 0 with redistribution rights.
Never published
Home address, family, personal contacts, health, and history unrelated to the public role
Profile claimed
No
Open disputes
0
Identity ownership
unclaimed
Claim this profileSuggest an edit

If the subject claims the profile, their statements appear as their own assertion state, subject attested. They never overwrite the evidence.

Evidence

Authority and rights
  1. E1
    XZO DEF 14A executive officers
    SEC EDGAR. sec filing. Published Apr 29, 2026. Retrieved May 16, 2026. Cited by 6 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    Source title not published
    sec proxy. Published Apr 29, 2026. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    Source title not published
    sec proxy. Published Apr 29, 2026. Retrieved Sep 2, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    Source title not published
    sec def 14a. Published Apr 29, 2026. Retrieved Sep 14, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    RVPH 10-K executive officers
    SEC EDGAR. sec filing. Published Mar 30, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    CRAC 10-K executive officers
    SEC EDGAR. sec filing. Published Mar 27, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    WGRX 10-K executive officers
    SEC EDGAR. sec filing. Published Mar 20, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    HCIIP 10-K executive officers
    SEC EDGAR. sec filing. Published Feb 26, 2026. Retrieved Jul 28, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  9. E9
    HCI 10-K executive officers
    SEC EDGAR. sec filing. Published Feb 26, 2026. Retrieved May 16, 2026. Cited by 2 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  10. E10
    RVPH DEF 14A director slate
    SEC EDGAR. sec filing. Published Nov 4, 2025. Retrieved May 16, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  11. E11
    Source title not published
    sec proxy. Published Nov 4, 2025. Retrieved Apr 25, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  12. E12
    Source title not published
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  13. E13
    Source title not published
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  14. E14
    Source title not published
    public source. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-0:d751713988987e9331980363e24189ce

vpublic-0:d751713988987e9331980363e24189ce published Sep 2, 2026
  • Paresh Patel seat on Exzeo Group, Inc., effective 2020-01-01.
  • Director at REVIVA PHARMACEUTICALS HOLDINGS, INC., effective 2020-01-01.
  • Paresh Patel seat on HCI Group, Inc., effective 2007-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:person:purav-patel, version public-0:d751713988987e9331980363e24189ce. https://registry.alpha.ac/people/purav-patel

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Board service9
  4. Committees0
  5. Work experience6
  6. Education and credentials0
  7. AI, cyber, technology3
  8. Authority to act8
  9. Compensation0
  10. Conflicts and accountability0
  11. Other published claims8
  12. Coverage gaps4
  13. Linked records4
  14. Subject and corrections6
  15. Evidence14
  16. Version historyvpublic-0:d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:person:purav-patel
  • Cite this recordParesh Patel
  • Copy canonical URLregistry.alpha.ac/people/purav-patel
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    Paresh PatelPerson
  • Exzeo Group, Inc.Company
  • HCI Group, Inc.Company
  • Sections
    OverviewParesh Patel
  • MonitoringParesh Patel
  • Board serviceParesh Patel
  • CommitteesParesh Patel
  • Work experienceParesh Patel
  • Education and credentialsParesh Patel
  • AI, cyber, technologyParesh Patel
  • Authority to actParesh Patel
  • CompensationParesh Patel
  • Conflicts and accountabilityParesh Patel
  • Other published claimsParesh Patel
  • Coverage gapsParesh Patel
  • Linked recordsParesh Patel
  • Subject and correctionsParesh Patel
  • EvidenceParesh Patel
  • Version historyParesh Patel
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.